For Institutions
About
Financial giants are making bullish moves on Philip Morris Intl, with 53% of traders showing bullish tendencies. Options history reveals a targeted price range of $80 to $200. Analysts propose an average target price of $185, with JP Morgan maintaining an Overweight rating. The stock is up 0.37% at $162.66, and RSI indicators suggest it may be approaching overbought. Next earnings are expected in 43 days.
Palantir Technologies Inc (NASDAQ:PLTR) has been a standout performer in 2025, consistently beating earnings estimates and showing significant revenue growth. The company raised its guidance for Q4 and has outperformed the S&P 500, gaining approximately 156% year-to-date. Analysts have raised price targets, with some expecting the stock to exceed $200. Palantir's strong balance sheet and high growth profile place it on the 'Nice' list for 2025, with expectations of continued success into 2026.
Philip Morris International (NYSE:PM) experienced a significant increase in options trading, with 265,612 call options acquired, marking a 2,300% rise from the average volume. The stock rose 0.4% to $162.78, with a market cap of $253.38 billion. Analysts maintain a "Moderate Buy" rating with a $189 average price target. The company announced a quarterly dividend of $1.47, yielding 3.6% annually.
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their fiduciary duties to shareholders. Shareholders are encouraged to contact the firm to discuss their rights and potential corporate governance reforms, financial incentives, or other relief. The firm handles actions on a contingent fee basis. Contact Daniel Sadeh or Zachary Halper for more information.
The U.S. stock market is reaching new highs, with tech stocks leading gains. Investors are eyeing high-growth sectors for opportunities. Top tech companies like Marker Therapeutics, Palantir, and Workday show significant revenue and earnings growth. Viant Technology, Dynavax Technologies, and Phreesia are highlighted for their strategic moves and financial growth. Viant focuses on advertising tech, Dynavax on vaccines, and Phreesia on healthcare software. The article encourages exploring 73 high-growth tech and AI stocks for potential investment opportunities.
